Literature DB >> 27496042

The Neurotoxic TAU45-230 Fragment Accumulates in Upper and Lower Motor Neurons in Amyotrophic Lateral Sclerosis Subjects.

Claudia R Vintilescu1, Sana Afreen1, Ashlee E Rubino1, Adriana Ferreira1.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a progressive and lethal neurodegenerative disease characterized by the loss of upper and lower motor neurons leading to muscle paralysis in affected individuals. Numerous mechanisms have been implicated in the death of these neurons. However, the pathobiology of this disease has not been completely elucidated. In the present study, we investigated to what extent tau cleavage and the generation of the neurotoxic tau45-230 fragment is associated with ALS. Quantitative Western blot analysis indicated that high levels of tau45-230 accumulated in lumbar and cervical spinal cord specimens obtained from ALS subjects. This neurotoxic tau fragment was also detected in ALS upper motor neurons located in the precentral gyrus. Our results also showed that tau45-230 aggregates were present in the spinal cord of ALS patients. On the other hand, this neurotoxic fragment was not generated in a mouse model of a familial form of this disease. Together, these results suggest a potential role for this neurotoxic tau fragment in the mechanisms leading to the degeneration of motor neurons in the context of sporadic ALS.

Entities:  

Keywords:  calpain; degeneration; neurotoxicity; pathogenesis; tau cleavage

Year:  2016        PMID: 27496042      PMCID: PMC5072411          DOI: 10.2119/molmed.2016.00095

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  66 in total

Review 1.  Amyotrophic lateral sclerosis as a complex genetic disease.

Authors:  Claire L Simpson; Ammar Al-Chalabi
Journal:  Biochim Biophys Acta       Date:  2006-08-05

2.  Neurodegeneration: An expansion in ALS genetics.

Authors:  Clotilde Lagier-Tourenne; Don W Cleveland
Journal:  Nature       Date:  2010-08-26       Impact factor: 49.962

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 4.  TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration.

Authors:  Clotilde Lagier-Tourenne; Magdalini Polymenidou; Don W Cleveland
Journal:  Hum Mol Genet       Date:  2010-04-15       Impact factor: 6.150

5.  Identification of oligomers at early stages of tau aggregation in Alzheimer's disease.

Authors:  Cristian A Lasagna-Reeves; Diana L Castillo-Carranza; Urmi Sengupta; Jose Sarmiento; Juan Troncoso; George R Jackson; Rakez Kayed
Journal:  FASEB J       Date:  2012-01-17       Impact factor: 5.191

6.  Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1.

Authors:  L I Bruijn; M K Houseweart; S Kato; K L Anderson; S D Anderson; E Ohama; A G Reaume; R W Scott; D W Cleveland
Journal:  Science       Date:  1998-09-18       Impact factor: 47.728

7.  TDP-43 dimerizes in human cells in culture.

Authors:  Yuki Shiina; Kunimasa Arima; Hiroko Tabunoki; Jun-ichi Satoh
Journal:  Cell Mol Neurobiol       Date:  2009-12-31       Impact factor: 5.046

8.  Elevated expression of TDP-43 in the forebrain of mice is sufficient to cause neurological and pathological phenotypes mimicking FTLD-U.

Authors:  Kuen-Jer Tsai; Chun-Hung Yang; Yen-Hsin Fang; Kuan-Hung Cho; Wei-Lin Chien; Wei-Ting Wang; Tzu-Wei Wu; Ching-Po Lin; Wen-Mei Fu; Che-Kun James Shen
Journal:  J Exp Med       Date:  2010-07-26       Impact factor: 14.307

9.  Processes induced by tau expression in Sf9 cells have an axon-like microtubule organization.

Authors:  P W Baas; T P Pienkowski; K S Kosik
Journal:  J Cell Biol       Date:  1991-12       Impact factor: 10.539

10.  Internalized Tau Oligomers Cause Neurodegeneration by Inducing Accumulation of Pathogenic Tau in Human Neurons Derived from Induced Pluripotent Stem Cells.

Authors:  Marija Usenovic; Shahriar Niroomand; Robert E Drolet; Lihang Yao; Renee C Gaspar; Nathan G Hatcher; Joel Schachter; John J Renger; Sophie Parmentier-Batteur
Journal:  J Neurosci       Date:  2015-10-21       Impact factor: 6.167

View more
  10 in total

1.  Increased Tau Phosphorylation in Motor Neurons From Clinically Pure Sporadic Amyotrophic Lateral Sclerosis Patients.

Authors:  Claire H Stevens; Natalie J Guthrie; Marloes van Roijen; Glenda M Halliday; Lezanne Ooi
Journal:  J Neuropathol Exp Neurol       Date:  2019-07-01       Impact factor: 3.685

2.  AD-Related N-Terminal Truncated Tau Is Sufficient to Recapitulate In Vivo the Early Perturbations of Human Neuropathology: Implications for Immunotherapy.

Authors:  A Borreca; V Latina; V Corsetti; S Middei; S Piccinin; F Della Valle; R Bussani; M Ammassari-Teule; R Nisticò; P Calissano; G Amadoro
Journal:  Mol Neurobiol       Date:  2018-03-05       Impact factor: 5.590

Review 3.  Roles of tau protein in health and disease.

Authors:  Tong Guo; Wendy Noble; Diane P Hanger
Journal:  Acta Neuropathol       Date:  2017-04-06       Impact factor: 17.088

4.  The formation of small aggregates contributes to the neurotoxic effects of tau45-230.

Authors:  Sana Afreen; Adriana Ferreira
Journal:  Neurochem Int       Date:  2021-11-29       Impact factor: 3.921

Review 5.  The roles of intrinsic disorder-based liquid-liquid phase transitions in the "Dr. Jekyll-Mr. Hyde" behavior of proteins involved in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.

Authors:  Vladimir N Uversky
Journal:  Autophagy       Date:  2017-12-17       Impact factor: 16.016

Review 6.  Molecular, functional, and pathological aspects of TDP-43 fragmentation.

Authors:  Deepak Chhangani; Alfonso Martín-Peña; Diego E Rincon-Limas
Journal:  iScience       Date:  2021-04-21

Review 7.  Phosphorylation of Threonine 175 Tau in the Induction of Tau Pathology in Amyotrophic Lateral Sclerosis-Frontotemporal Spectrum Disorder (ALS-FTSD). A Review.

Authors:  Alexander J Moszczynski; Matthew A Hintermayer; Michael J Strong
Journal:  Front Neurosci       Date:  2018-04-20       Impact factor: 4.677

8.  Notch Signalling in the Hippocampus of Patients With Motor Neuron Disease.

Authors:  Ulises Gómez-Pinedo; Lucía Galán; Jordi A Matías-Guiu; Vanesa Pytel; Teresa Moreno; Antonio Guerrero-Sola; Jorge Matías-Guiu
Journal:  Front Neurosci       Date:  2019-04-05       Impact factor: 4.677

Review 9.  Alterations in Tau Metabolism in ALS and ALS-FTSD.

Authors:  Michael J Strong; Neil S Donison; Kathryn Volkening
Journal:  Front Neurol       Date:  2020-11-23       Impact factor: 4.003

Review 10.  Tau Proteolysis in the Pathogenesis of Tauopathies: Neurotoxic Fragments and Novel Biomarkers.

Authors:  James P Quinn; Nicola J Corbett; Katherine A B Kellett; Nigel M Hooper
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.